ClinVar Miner

Submissions for variant NM_003119.4(SPG7):c.739C>T (p.Arg247Ter)

gnomAD frequency: 0.00001  dbSNP: rs779055639
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001220525 SCV001392520 pathogenic Hereditary spastic paraplegia 7 2023-11-27 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Arg247*) in the SPG7 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPG7 are known to be pathogenic (PMID: 21623769, 22964162). This variant is present in population databases (rs779055639, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with hereditary spastic paraplegia (PMID: 21623769). ClinVar contains an entry for this variant (Variation ID: 949128). For these reasons, this variant has been classified as Pathogenic.
Genetic Services Laboratory, University of Chicago RCV001819912 SCV002064530 pathogenic not provided 2019-01-08 criteria provided, single submitter clinical testing DNA sequence analysis of the SPG7 gene demonstrated a sequence change, c.739C>T, which results in the creation of a premature stop codon at amino acid position 247, p.Arg247*. This pathogenic sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated SPG7 protein with potentially abnormal function. This sequence change has been described in the gnomAD database with a low population frequency of 0.0022% (rs779055639). This sequence change has previously been described in a patient with spastic paraplegia in the compound heterozygous state with a missense pathogenic variant (Schlipf et al., 2011).
Fulgent Genetics, Fulgent Genetics RCV001220525 SCV002807925 pathogenic Hereditary spastic paraplegia 7 2021-11-29 criteria provided, single submitter clinical testing
GeneDx RCV001819912 SCV004168302 pathogenic not provided 2023-05-11 criteria provided, single submitter clinical testing Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 30683863, 21623769, 34758253)
PROSPAX: an integrated multimodal progression chart in spastic ataxias, Center for Neurology; Hertie-Institute for Clinical Brain Research RCV001220525 SCV005061886 pathogenic Hereditary spastic paraplegia 7 2022-01-01 criteria provided, single submitter research
Genomics England Pilot Project, Genomics England RCV001220525 SCV001760387 pathogenic Hereditary spastic paraplegia 7 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.